ClinicalTrials.gov record
Dose Response Study of a Topical Gel for the Treatment of Raynaud's Phenomenon
COMPLETED · NCT00378521
Trial record
NCT IDNCT00378521
Status
COMPLETED
Study type
INTERVENTIONAL
Phase
PHASE2
Enrollment
15
Conditions
Raynaud's Disease, Raynaud's Disease Secondary to Scleroderma, Raynaud's Disease Secondary to Autoimmune Disease
Interventions
MQX-503
Locations
Rainier Clinical Research, Renton, Washington, United States
Indexed topics
Last update
2007-05-29